​

Funding Round

Series A - Santero Therapeutics

Series A - Santero Therapeutics

Investment Firm

Overview

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

Announced Date

Jun 08, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorSFPIM
Participant InvestorSambrinvest
Participant InvestorPierre Drion
Participant InvestorS.R.I.W.

Round Details and Background

Santero Therapeutics raised $8625644 on 2023-06-08 in Series A

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 08, 2023
Series A - Santero Therapeutics
5-8.6M

Recent Activity

There is no recent news or activity for this profile.